Riskpilot← Back to searchSign inGet full accessCPT.one BIOTECH ApS
APSDissolvedCVR 35484558Langelinie Allé 17Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900Est. 20131 employees
Revenue 2020
DKK -1,7M
+631% vs 2019
EBITDA margin
118.4%
-766% vs 2019
Equity ratio
-73.5%
Financial strength
Net profit 2020
DKK -2,1M
-654% vs 2019
| Revenue | DKK -1,7M | +631% |
| EBITDA | DKK -2M | -766% |
| Net profit | DKK -2,1M | -654% |
| Total assets | DKK 5,1M | +20% |
| Equity | DKK -3,8M | -131% |
| Employees | 1 | — |
Legal name
CPT.one BIOTECH ApS
CVR number
35484558
Legal form
Anpartsselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
1. oktober 2013
Share capital
DKK 114.286
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Langelinie Allé 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | -41 | -169 | -94 | -142 | -231 | -232 | -1.700 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -313 |
| EBITDA | -41 | -169 | -94 | -142 | -231 | -232 | -2.014 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -41 | -169 | -94 | -142 | -231 | -232 | -2.014 |
| Net financials | -192 | -161 | -173 | -372 | -311 | -101 | -133 |
| Profit before tax | -233 | -330 | -267 | -514 | -541 | -333 | -2.146 |
| Tax | -55 | -77 | -59 | -113 | -119 | -48 | -0 |
| Net profit | -178 | -253 | -209 | -401 | -422 | -285 | -2.146 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|
| Total assets | 2.699 | 2.783 | 2.851 | 3.234 | 3.531 | 4.287 | 5.143 |
| Equity | -98 | -317 | -526 | -927 | -1.349 | -1.634 | -3.780 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 1.750 | 7.172 |
| Short-term debt | 2.797 | 3.099 | 3.377 | 4.161 | 4.881 | 4.171 | 1.752 |
| Total debt | 2.797 | 3.099 | 3.377 | 4.161 | 4.881 | 5.921 | 8.923 |
EBITDA margin
-201357900.0%
This company
15.8%
Market median
-1274417189% vs market
20142020
Equity ratio
-73.5%
This company
38.2%
Market median
-292% vs market
20142020
Return on equity
-214615300.0%
This company
18.4%
Market median
-1166387600% vs market
20142020
Net profit margin
-214615300.0%
This company
8.1%
Market median
-2649571705% vs market
20142020
Asset turnover
-0.33×
This company
1.12×
Market median
-129% vs market
20142020
Debt / equity
2.36×
This company
0.62×
Market median
-281% vs market
20142020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FN Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MG Management | Management | 2016 | — | — |
IS Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
PP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
SG Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2014 | — | — | |
| Deputy Chairman | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.0% | 5.0% | 2015 | |
ACINDRIA ApS | Company | 66.7% | 66.7% | 2019 |
| Individual | 15.0% | 15.0% | 2018 | |
Equivalent ApS | Company | 5.0% | 5.0% | 2020 |
SAUNDERS HOLDING ApS | Company | 10.0% | 10.0% | 2015 |
NORDIC BIOTECH HOLDING ApS | Company | 10.0% | 10.0% | 2020 |
LEEWARD ApS | Company | 10.0% | 10.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CPT.one BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frederik Nicolaj Mørkeberg Andersen | Chief Executive Officer | 0 companies |
| Martin Goller Kloth | Management | 0 companies |
| Ingelise Saunders | Chief Executive Officer | 0 companies |
| Peter Popowicz | Chief Executive Officer | 0 companies |
| Sigbjørn Georg Nielsen Kjærgård | Chief Executive Officer | 0 companies |
| Keld Nomanni | Board of Directors | 0 companies |
| Jarne Elleholm | Chairman | 0 companies |
| Jette Goller Kloth Nieland | Deputy Chairman | 0 companies |
| Peter Heinrich | Chairman | 0 companies |